[1] |
中华医学会神经病学分会神经免疫学组.多发性硬化诊断与治疗中国指南(2023 版)[J]. 中华神经科杂志,2024,57(1):10-23.DOI:10.3760/cma.j.cn113694-20230918-00173.Chinese Society of Neuroimmunology. Chinese guidelines for diagnosis and treatment of multiple sclerosis (2023 edition)[J].Chin J Neurol,2024,57(1):10-23.DOI:10.3760/cma.j.cn113694-20230918-00173.
|
[2] |
Tian DC,Zhang C,Yuan M,et al. Incidence of multiple sclerosis in China:a nationwide hospital-based study[J].Lancet Reg Health West Pac,2020,1:100010.DOI:10.1016/j.lanwpc.2020.100010.
|
[3] |
Welsh JA,Goberdhan DCI,O ' Driscoll L,et al. Minimal information for studies of extracellular vesicles (MISEV2023):from basic to advanced approaches[J]. J Extracell Vesicles,2024,13(2):e12404.DOI:10.1002/jev2.12404.
|
[4] |
EL Andaloussi S,Mäger I,Breakefield XO,et al. Extracellular vesicles:Biology and emerging therapeutic opportunities[J]. Nat Rev Drug Discov,2013,12(5):347-357.DOI:10.1038/nrd3978.
|
[5] |
Iannotta D,Amruta A,Kijas AW,et al. Entry and exit of extracellular vesicles to and from the blood circulation[J]. Nat Nanotechnol,2024,19(1):13-20. DOI:10.1038/s41565-023-01522-z.
|
[6] |
Morad G,Carman CV,Hagedorn EJ,et al. Tumor - derived extracellular vesicles breach the intact blood-brain barrier via transcytosis[J]. ACS Nano,2019,13(12):13853 - 13865. DOI:10.1021/acsnano.9b04397.
|
[7] |
Hervé F,Ghinea N,Scherrmann JM. CNS delivery via adsorptive transcytosis[J].AAPS J,2008,10(3):455-472.DOI:10.1208/s12248-008-9055-2.
|
[8] |
Riazifar M,Mohammadi MR,Pone EJ,et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders[J]. ACS Nano,2019,13(6):6670-6688. DOI:10.1021/acsnano.9b01004.
|
[9] |
Lessey-Morillon EC,Osborne LD,Monaghan-Benson E,et al.The RhoA guanine nucleotide exchange factor,LARG,mediates ICAM-1-dependent mechanotransduction in endothelial cells to stimulate transendothelial migration[J]. J Immunol,2014,192(7):3390-3398.DOI:10.4049/jimmunol.1302525.
|
[10] |
Zeng Z,Li Y,Pan Y,et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis[J]. Nat Commun,2018,9(1):5395.DOI:10.1038/s41467-018-07810-w.
|
[11] |
Treps L,Perret R,Edmond S,et al. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles[J]. J Extracell Vesicles,2017,6(1):1359479. DOI:10.1080/20013078.2017.1359479.
|
[12] |
Tominaga N,Kosaka N,Ono M,et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier[J]. Nat Commun,2015,6:6716.DOI:10.1038/ncomms7716.
|
[13] |
De La Cruz EM. How cofilin severs an actin filament[J]. Biophys Rev,2009,1(2):51-59.DOI:10.1007/s12551-009-0008-5.
|
[14] |
Lai CP,Breakefield XO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies[J]. Front Physiol,2012,3:228.DOI:10.3389/fphys.2012.00228.
|
[15] |
Gardiner C,Di Vizio D,Sahoo S,et al. Techniques used for the isolation and characterization of extracellular vesicles:results of a worldwide survey[J]. J Extracell Vesicles,2016,5:32945. DOI:10.3402/jev.v5.32945.
|
[16] |
Li J,Lu S,Chen F,et al.Unveiling the hidden role of extracellular vesicles in brain metastases:a comprehensive review[J]. Front Immunol,2024,15:1388574.DOI:10.3389/fimmu.2024.1388574.
|
[17] |
Welton JL,Loveless S,Stone T,et al. Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis[J]. J Extracell Vesicles,2017,6(1):1369805.DOI:10.1080/20013078.2017.1369805.
|
[18] |
Scolding NJ,Frith S,Linington C,et al. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation[J]. J Neuroimmunol,1989,22(3):169-176. DOI:10.1016/0165-5728(89)90014-3.
|
[19] |
Jy W,Minagar A,Jimenez JJ,et al. Endothelial microparticles(EMP) bind and activate monocytes:elevated EMP - monocyte conjugates in multiple sclerosis[J]. Front Biosci,2004,9:3137-3144.DOI:10.2741/1466.
|
[20] |
Lombardi M,Parolisi R,Scaroni F,et al. Detrimental and protective action of microglial extracellular vesicles on myelin lesions:astrocyte involvement in remyelination failure[J]. Acta Neuropathol,2019,138(6):987-1012.DOI:10.1007/s00401-019-02049-1.
|
[21] |
Krämer-Albers EM,Bretz N,Tenzer S,et al. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins:Trophic support for axons?[J]. Proteomics Clin Appl,2007,1(11):1446-1461.DOI:10.1002/prca.200700522.
|
[22] |
Torres Iglesias G,Fernández-Fournier M,Botella L,et al. Brain and immune system - derived extracellular vesicles mediate regulation of complement system,extracellular matrix remodeling,brain repair and antigen tolerance in Multiple sclerosis[J]. Brain Behav Immun,2023,113:44-55.DOI:10.1016/j.bbi.2023.06.025.
|
[23] |
Blandford SN,Fudge NJ,Corkum CP,et al. Analysis of plasma using flow cytometry reveals increased immune cell - derived extracellular vesicles in untreated relapsing-remitting multiple sclerosis[J]. Front Immunol,2022,13:803921. DOI:10.3389/fimmu.2022.803921.
|
[24] |
Groen K,Maltby VE,Scott RJ,et al. Concentrations of plasmaborne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls[J]. Mult Scler Relat Disord,2020,45:102446.DOI:10.1016/j.msard.2020.102446.
|
[25] |
Mazzucco M,Mannheim W,Shetty SV,et al. CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis[J]. Fluids Barriers CNS,2022,19(1):13. DOI:10.1186/s12987-021-00299-4.
|
[26] |
Torres Iglesias G,Fernández-Fournier M,López-Molina M,et al.Dual role of peripheral B cells in multiple sclerosis:emerging remote players in demyelination and novel diagnostic biomarkers[J].Front Immunol,2023,14:1224217.DOI:10.3389/fimmu.2023.1224217.
|
[27] |
Agliardi C,Guerini FR,Zanzottera M,et al. Myelin basic protein in oligodendrocyte-derived extracellular vesicles as a diagnostic and prognostic biomarker in multiple sclerosis:a pilot study[J].Int J Mol Sci,2023,24(1):894.DOI:10.3390/ijms24010894.
|
[28] |
D'Ambrosio A,Zamboni S,Camerini S,et al. Proteomic profile of extracellular vesicles from plasma and CSF of multiple sclerosis patients reveals disease activity - associated EAAT2[J]. J Neuroinflammation,2024,21(1):217. DOI:10.1186/s12974-024-03148-x.
|
[29] |
Duan J,Lv A,Guo Z,et al. CX3CR1+/UCHL1+ microglial extracellular vesicles in blood:a potential biomarker for multiple sclerosis[J]. J Neuroinflammation,2024,21(1):254. DOI:10.1186/s12974-024-03243-z.
|
[30] |
Vietzen H,Berger SM,Kühner LM,et al. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis[J]. Cell,2023,186(26):5705-5718.e13. DOI:10.1016/j.cell.2023.11.015.
|
[31] |
Levin LI,Munger KL,Rubertone MV,et al.Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis[J]. JAMA,2005,293(20):2496-500.DOI:10.1001/jama.293.20.2496.
|
[32] |
Fernández-Fournier M,López-Molina M,Torres Iglesias G,et al.Antibody content against Epstein-Barr virus in blood extracellular vesicles correlates with disease activity and brain volume in patients with relapsing-remitting multiple sclerosis[J]. Int J Mol Sci,2023,24(18):14192.DOI:10.3390/ijms241814192.
|
[33] |
Bhargava P,Nogueras - Ortiz C,Kim S,et al. Synaptic and complement markers in extracellular vesicles in multiple sclerosis[J]. Mult Scler,2021,27(4):509-518. DOI:10.1177/135245852 0924590.
|
[34] |
Cuomo-Haymour N,Bergamini G,Russo G,et al. Differential expression of serum extracellular vesicle miRNAs in multiple sclerosis:disease-stage specificity and relevance to pathophysiology[J].Int J Mol Sci,2022,23(3):1664.DOI:10.3390/ijms23031664.
|
[35] |
Ebrahimkhani S,Beadnall HN,Wang C,et al. Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment[J]. Mol Neurobiol,2020,57(2):1245-1258.DOI:10.1007/s12035-019-01792-6.
|
[36] |
Peruzzotti-Jametti L,Bernstock JD,Willis CM,et al. Neural stem cells traffic functional mitochondria via extracellular vesicles[J].PLoS Biol,2021,19(4):e3001166. DOI:10.1371/journal.pbio.3001166.
|
[37] |
Ladakis DC,Yao PJ,Vreones M,et al. Mitochondrial measures in neuronally enriched extracellular vesicles predict brain and retinal atrophy in multiple sclerosis[J]. Mult Scler,2022,28(13):2020-2026.DOI:10.1177/13524585221106290.
|
[38] |
江飞,黄会青,陈文东,等.中国多发性硬化症患者认知功能障碍现状及危险因素分析[J]. 神经损伤与功能重建,2022,17(12):775-778.DOI:10.16780/j.cnki.sjssgncj.20220236.Jiang F,Huang HQ,Chen WD,et al. Current status of cognitive impairment and analysis of risk factors in patients with multiple sclerosis in China[J]. Neural Injury and Functional Reconstruction,2022,17(12):775-778.DOI:10.16780/j.cnki.sjssgncj.20220236.
|
[39] |
Ladakis DC,Vreones M,Blommer J,et al.Synaptic protein loss in extracellular vesicles reflects brain and retinal atrophy in people with multiple sclerosis[J]. Neurol Neuroimmunol Neuroinflamm,2024,11(4):e200257.DOI:10.1212/NXI.0000000000200257.
|
[40] |
Riazifar M,Mohammadi MR,Pone EJ,et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders[J]. ACS Nano,2019,13(6):6670-6688. DOI:10.1021/acsnano.9b01004.
|
[41] |
Xiao Y,Tian J,Wu WC,et al. Targeting central nervous system extracellular vesicles enhanced triiodothyronine remyelination effect on experimental autoimmune encephalomyelitis[J]. Bioact Mater,2021,9:373-384.DOI:10.1016/j.bioactmat.2021.07.017.
|
[42] |
Osorio-Querejeta I,Carregal-Romero S,Ayerdi-Izquierdo A,et al. MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles[J]. Pharmaceutics,2020,12(2):186.DOI:10.3390/pharmaceutics12020186.
|
[43] |
Niu W,Xiao Q,Wang X,et al.A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicinloaded heparin-based nanoparticles for glioma therapy[J]. Nano Lett,2021,21(3):1484-1492.DOI:10.1021/acs.nanolett.0c04753.
|